NCT05660642: An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
- State
- Under way
- Phase
- Phase 2
- People
- 72 planned
- Started
- 10 Feb 2023
- Primary completion
- Nov 2026
- Arms
- Arm A, Arm B
- Results
- None posted
- 21 Dec 2022: Trial registered
- 10 Feb 2023: Trial started